Emerald Health Pharmaceuticals’ Cannabinoid-Derived Drug Shows Potential for Remyelination and Disease Modification for Multiple Sclerosis
CBS8,
Journal of Neuroinflammation Paper Highlights Anti-Inflammatory and Neuroprotective Properties of EHP-101 and Potential to…